• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dissecting OCM Performance Period 4 Results and Their Implications

Podcast

With Oncology Care Model performance period 4 results out now, it’s a transformative point in the model in which practices that have not yet achieved a performance-based payment have to either enter 2-sided risk or leave the model. To dive into the most recent results and their implications, we spoke with Charles Saunders, MD, chief executive officer of Integra Connect.

Now 3 years into the Oncology Care Model, practices participating in the episode-based model have recently received results from performance period 4, representing care delivered in the first half of 2018. Results from the previous 2 performance periods have some practices concerned because there was little improvement; During both performance period 2 and 3 approximately 30% of practices achieved savings.

With performance period 4 results out now, it’s a transformative point in the model in which practices that have not yet achieved a performance-based payment have to either enter 2-sided risk or leave the model. To dive into the most recent results and their implications, we spoke with Charles Saunders, MD, chief executive officer of Integra Connect.

iTunes

TuneIn

Stitcher

Spotify

Read more about the Oncology Care Model performance period results:

Lessons From the Field: How Practices Are Succeeding Under OCM

Mike Fazio: Practices Are Happier With PP4 Results in the OCM

COA Submits OCM 2.0 Proposal

COA Urges Delay in Downside Risk Deadline for OCM

Listen above or through one of these podcast services:

Related Videos
Jennifer Sturgill, DO, Central Ohio Primary Care
Kristin Oaks, DO, Cental Ohio Primary Care
Kristine Slam, MD, Central Ohio Surgical Associates
Jennifer Sturgill, DO, Central Ohio Primary Care
Kristin Oaks, DO, Central Ohio Primary Care
Kristine Slam, MD, FACP, Central Ohio Surgical Associates
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Susan Escudier, MD, FACP, vice president, value-based and quality programs for Texas Oncology
Sam Holliday, Oshi Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.